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SUMMARY. Several dermal products have been introduced to substitute dermal tissues. In this study we review the effects of these
products on repairing third-degree burn wounds and managing complications in animal specimens. Using an interventional approach, rats
were randomly assigned to four groups (G1 to G4). Two wounds were created on the back of each rat. An open wound was left on the back
of rats in G1; in G2, wounds were covered with a thick rat derived-ADM product and overlying thin skin graft; on G3 rats, similar third
degree ulcers were made with one ulcer covered with harvested thin skin graft. In G4, ulcers were covered with a thin rat derived-ADM
product and thin graft. Factors such as take rate, histopathological score, wound contracture and graft contracture were compared on the
7th, 15th, 21st and 30th day. Mean graft take rate on the 30th day in the thick ADM, thin ADM and graft group showed a significant dif-
ference (p=0.015). Histopathological score on the 30th day in the thin ADM, thick ADM and graft group showed no considerable difference.
Mean graft take rate was significantly better in the thin ADM and graft group than in the thick ADM group. Wound contracture was sig-
nificantly more severe in the thick ADM and control group than in the thin ADM and graft group.
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Plusieurs produits ont été introduits dans le but de substituer le derme. Dans cette étude, nous avons étudié l’effet de ces
produits sur la cicatrisation et la gestion des complications après brûlure expérimentale. Nous avons étudié 4 groupes (G1 à G4) de rats
ayant subi deux brûlures du dos. Celles de G1 étaient laissées à l’air, G2 recevaient un Derme Artificiel Acellulaire (DAA) dérivé de rats
épais recouvert d’une greffe fine, G3 recevaient une greffe conservée, G4 recevaient DAA fin et greffe fine. Le taux de prise de greffe, le
score histologique, la rétraction de la brûlure et de la greffe ont été comparés à J7, J15, J21 et J30. A J30, les taux de prise de greffe
étaient significativement différents entre G2, G3 et G4 (p=0,015), étant moins bons en cas d’utilisation de DAA en couche épaisse. De
même, la rétraction était plus intense après utilisation de DAA en couche épaisse qu’en couche fine ou après greffe seule. Les résultats
histologiques étaient comparables. 
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Introduction
Plastic and burn surgeons have always found it challenging
to achieve desirable cosmetic results when treating burns and
traumas with full thickness skin damage. Tissue contracture,
hypertrophic scarring and contour deformity are the most com-
mon complications that need to be addressed.1-3
These complications are often managed with dermal sub-
stitutes, particularly acellular dermal matrix (ADM) grafts
which result in improved scar parameters.4,5,6 These products
provide a 3-dimensional matrix at the ulcer bed and help with
focal vascularisation and fibroblast activity, which in turn leads
to optimal and natural development of skin tissue.7
Several products have been introduced in different countries
with varying clinical and experimental results. These include Allo-
derm, FlexHD, Neoform, Dermamatrix and Surgimend (human de-
rived ADM), Strattice and Permacol (porcine-derived ADM). 
In this study, we used an ADM product on rat specimens. This
product was prepared by the “Iranian Tissue Product Company”
at Tehran University of Medical Sciences.
Our study aimed to evaluate the effectiveness of our product,
and its efficacy in supporting early skin grafts. We also compared
thin and thick ADMs in terms of graft take and contracture rate.
Methods
The study was approved by the Ethics Committee of Iran
University of Medical Sciences.
For ADM preparation, we used laboratory rat skin. Throughout
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the whole project, we followed national and international principles
regarding caring for and using animals in experimental studies. 
We chose male specimens weighing over 350 grams, and
took the following steps to prepare the grafts:
1. Death was induced by CO2 inhalation;
2. The rat’s back skin was shaved;
3. The skin was excised with power dermatome;
4. The skin was kept in a hypertonic saline incubator for
24 hours in order to facilitate separation of dermis and
epidermis;
5. The epidermis and underlying adipose tissue were
separated in a Class-100 Cleanroom under laminar hood;
6. The epidermis was treated with dispose, Triton X-100
and Pen Strep for a limited period of time;
7. The epidermis was rinsed multiple times;
8. It was then treated with cellular enzymatic lysis
(Trypsin, Pen Strep and EDTA);
9. Final rinsing with PBS;
10. Lyophilisation;
11. Packaging and labelling for gamma irradiation;
12. Final sterilisation with gamma radiation;
13. Two types of ADM were prepared - thick ADM (0.6mm
thickness) and thin ADM (0.4mm thickness).
At the end of preparation, the MTT (3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was
used to assess the immunogenicity of the grafts. 
This is a colorimetric assay for assessing cell metabolic ac-
tivity of tissues.
In the second stage of the study, twenty rats of similar race,
age, gender and weight were anaesthetized by intramuscular
injection of Xylazine 2% (15mg/kg) (Alfasan Inc., Woerden,
the Netherlands) and Ketamine 10% (60mg/kg) (Alfasan Inc.,
Woerden, the Netherlands). Once anaesthetized, two full thick-
ness wounds were created on the back of each rat using derma-
tome, Aesculap. Each area measured 2×2 cm.
The rats were randomly assigned to 4 groups (G1 to G4),
each group including 5 rats. 
In G1, the wounds were left open. In G2, the wounds were
covered with thick ADM and overlaying thin skin autograft. In
G3, harvested thin skin graft was used to cover the wounds. In
G4, thin ADM and overlaying thin split-thickness skin graft
(STSG) was used to cover them. The areas were then covered
with vaseline and wet gauze. 
Two rats from G1 and G2 died, which resulted in four
wounds being excluded from our study. Hence, the number of
open wounds (G1), thick ADM (G2), thin ADM (G3), skin graft
(G4) and samples were 8, 8, 10 and 10 respectively.
The wounds were photographed on the 7th, 15th and 30th day
with a digital camera (Canon, PowerShot SX200 IS, Tokyo,
Japan) and several factors, such as graft take rate (GTR), residual
wound area (RWA) and healed wound area (HWA) were analyzed
using the ImageJ software programme (ver. 1.45, NIH, Maryland,
USA). Two burn surgeons, blinded to the type of graft, clinically
assessed the wounds in terms of graft colour and adherence. 
The following formulas were used to measure wound con-
traction rate (WCR) and graft contraction (GCR): 
• GTR = mean area of the graft take / mean area of wound X 100
• WCR = (wound area on 7th day – wound area on 30th day)/ wound
area on 7th day X 100
• GCR = (graft area on 7th day – graft area on 30th day) / graft
area on 7th day X 100
Wound biopsy was performed on the 15th and 30th day, and
it was stained with haematoxylin and eosin stain (H&E stain
or HE stain) (Fig. 1).
These were assessed with a histopathological scoring
(HPS) system, reported in Table I.8,9  Table II gives an exam-
ple of a graft taken totally. The total score for signs of “hea-
ling” and “rejection” would be 0-6 and 0-10 respectively. 
Fig. 1 - Histopathological results image. A: image on day 30 from skin in
the graft group; B: image on day 30 from skin in the open wound group;
C: image on day 30 from skin in the thick ADM group; D: image on day
30 from skin in the thin ADM group.   
Signs Scores
Healing and 
graft take
Epithelialization
Adherence
Collagen pattern
0 = none 1 = complete
0 = <25% 1 = 25-75%
2 = 76-99% 3 = 100%
0 = abnormal 1 = intermediate
2 = normal
Total: 0-6
Graft 
rejection
(Immunologic 
rejection)
Dermis and epidermis 
separation
Fibroplasia
Inflammatory cells
Epidermal hyperplasia
Eosinophilia
0 = presence of findings
1 = intermediate 
2 = absence of findings
Total: 0-10
Table I - Criteria for the histopathological scoring (HPS) system
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A total score of 16 represents the best graft response,
and a score of 0 indicates the worst graft response. Graft
take also was clinically determined by an experienced burn
surgeon. 
These results were documented for all 4 groups on the
7th, 15th, 21st and 30th day. 
ANOVA and T-testing were used to ensure that the re-
sults were normalised.
Results
Ten wounds were inflicted in each group. The Kolmo-
gorov-Smirnov test was used to assess the variability of the
data and ensure the normalised variation of the quantitative
indices.
The difference in mean GTR among the groups is signi-
ficant on the 7th, 21st and 30th day, as seen in Table III.
HPS is significantly different on the 7th and 15th day in
all 4 groups. However, there is no significant difference in
the results of the binary comparison of G2, G3 and G4.
There is a remarkable difference in the binary comparison
of the results of G1 with each of the other three groups
(Table IV).
GCR and GWR are somewhat similar in the binary com-
parison between the groups. However, a significant diffe-
rence is seen for these two factors in the binary comparison
of G1 and each of the other groups.
Reviewing WCR in G1 on the 21st and 30th day shows
a significant difference (p<0.001). However, the other
groups did not follow the same trend (p>0.05) (Table V).
Discussion
The optimal surgical management for burn wounds has
been a subject of constant debate. The most crucial factor
to consider is the depth of the wound. The standard treat-
ments are early excision and grafting with a partial thick-
ness skin graft, which has a thin dermis layer. This often
leads to a slightly dipped and sunken appearance of the
grafted area, which may eventually require cosmetic sur-
gery. The thicker the dermal layer of the skin graft, the
lower the rate of wound dip and contracture. Contracture
could also be avoided by using another layer between the
ulcer bed and the graft; hence, the introduction of acellular
dermal matrices.
Factor Value Score
Epithelialization Complete 1
Adherence Complete 3
Collagen pattern Normal 2
Dermis and epidermis 
separation 
None 2
Fibroplasia None 2
Epidermal hyperplasia None 2
Eosinophilia None 2
Inflammatory cells None 2
Overall score 16
Table II - Histopathological scoring: example of graft taken totally
Table III - Binary comparison of mean graft take rate (GTR)
Table IV - Comparison of histopathological scores (HPS)
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Being expensive, the use of acellular grafts has remained limited.7
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leads to very good results, including better colour and skin elasticity,
as well as limited scarring. Another advantage of ADM is that con-
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A similar difference is seen among G1, G3 and G4 on days 21 and
30. Whilst WCR was not very different among the grafted groups
at any stage, a significant difference was noted between the graft
group and the open wound group.
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human use should be considered, following the necessary studies
in the human phase.
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